STUDY OBJECTIVE: The inhibitory neuromodulator adenosine has been proposed as a homeostatic sleep factor that acts potently in the basal forebrain (BF) to increase sleepiness. Here 300 microM of adenosine was dialyzed in the BF of rats, and the effect on vigilance was determined in the rat Psychomotor Vigilance Task (rPVT). DESIGN: Rats experienced all experimental conditions in a repeated-measures, cross-over design. PATIENTS OR PARTICIPANTS: Twelve young adult male Fischer-Norway rats. INTERVENTIONS: Sustained attention performance in the rPVT was evaluated following 2 hours of bilateral microdialysis perfusion of vehicle, adenosine (300 microM), or codialysis of 300 microM of adenosine with the A1 receptor antagonist 8-cyclopentyltheophylline. MEASUREMENTS AND RESULTS: During rPVT performance, response latencies and performance lapses increased significantly after adenosine dialysis when compared with baseline (no dialysis) or vehicle dialysis sessions. The codialysis of 8-cyclopentyltheophylline with adenosine completely blocked the effects produced by adenosine alone, resulting in performance equivalent to that of the vehicle sessions. CONCLUSIONS: Pharmacologic elevation of BF adenosine in rats produced vigilance impairments resembling the effect of sleep deprivation on vigilance performance in both man and rats. This effect of exogenous adenosine was completely blocked by codialysis with an adenosine A1 receptor antagonist. The results are consistent with the hypothesis that sleep loss induces elevations of BF adenosine that, acting via A1 receptors, lead to increased sleepiness and impaired vigilance.
STUDY OBJECTIVE: The inhibitory neuromodulator adenosine has been proposed as a homeostatic sleep factor that acts potently in the basal forebrain (BF) to increase sleepiness. Here 300 microM of adenosine was dialyzed in the BF of rats, and the effect on vigilance was determined in the rat Psychomotor Vigilance Task (rPVT). DESIGN:Rats experienced all experimental conditions in a repeated-measures, cross-over design. PATIENTS OR PARTICIPANTS: Twelve young adult male Fischer-Norway rats. INTERVENTIONS: Sustained attention performance in the rPVT was evaluated following 2 hours of bilateral microdialysis perfusion of vehicle, adenosine (300 microM), or codialysis of 300 microM of adenosine with the A1 receptor antagonist 8-cyclopentyltheophylline. MEASUREMENTS AND RESULTS: During rPVT performance, response latencies and performance lapses increased significantly after adenosine dialysis when compared with baseline (no dialysis) or vehicle dialysis sessions. The codialysis of 8-cyclopentyltheophylline with adenosine completely blocked the effects produced by adenosine alone, resulting in performance equivalent to that of the vehicle sessions. CONCLUSIONS: Pharmacologic elevation of BF adenosine in rats produced vigilance impairments resembling the effect of sleep deprivation on vigilance performance in both man and rats. This effect of exogenous adenosine was completely blocked by codialysis with an adenosine A1 receptor antagonist. The results are consistent with the hypothesis that sleep loss induces elevations of BF adenosine that, acting via A1 receptors, lead to increased sleepiness and impaired vigilance.
Authors: Gregory Belenky; Nancy J Wesensten; David R Thorne; Maria L Thomas; Helen C Sing; Daniel P Redmond; Michael B Russo; Thomas J Balkin Journal: J Sleep Res Date: 2003-03 Impact factor: 3.981
Authors: Thomas J Balkin; Paul D Bliese; Gregory Belenky; Helen Sing; David R Thorne; Maria Thomas; Daniel P Redmond; Michael Russo; Nancy J Wesensten Journal: J Sleep Res Date: 2004-09 Impact factor: 3.981
Authors: Michael A Christie; James T McKenna; Nina P Connolly; Robert W McCarley; Robert E Strecker Journal: J Sleep Res Date: 2008-10-06 Impact factor: 3.981
Authors: Daniel A Cohen; Wei Wang; James K Wyatt; Richard E Kronauer; Derk-Jan Dijk; Charles A Czeisler; Elizabeth B Klerman Journal: Sci Transl Med Date: 2010-01-13 Impact factor: 17.956
Authors: Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley Journal: Physiol Rev Date: 2012-07 Impact factor: 37.312
Authors: Jordy van Enkhuizen; Dean Acheson; Victoria Risbrough; Sean Drummond; Mark A Geyer; Jared W Young Journal: Behav Brain Res Date: 2013-12-12 Impact factor: 3.332
Authors: John G McCoy; Michael A Christie; Youngsoo Kim; Robert Brennan; Devon L Poeta; Robert W McCarley; Robert E Strecker Journal: Neuroreport Date: 2013-01-23 Impact factor: 1.837
Authors: Christopher P Ward; John G McCoy; James T McKenna; Nina P Connolly; Robert W McCarley; Robert E Strecker Journal: Brain Res Date: 2009-07-28 Impact factor: 3.252